Endocrine Society RPHR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this book
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, E.
Right arrow Articles by Nevins, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, E.
Right arrow Articles by Nevins, J. R.
Recent Progress in Hormone Research 58:55-73 (2003)
© 2003 The Endocrine Society

Gene Expression Profiling for Prediction of Clinical Characteristics of Breast Cancer

Erich Huang*, Mike West{dagger} and Joseph R. Nevins*,{ddagger},||

* Department of Molecular Genetics and Microbiology; Duke University, Durham, North Carolina 27710
{dagger} Institute of Statistics and Decision Sciences; Duke University, Durham, North Carolina 27710
{ddagger} Howard Hughes Medical Institute; Duke University, Durham, North Carolina 27710
|| Duke University Medical Center; Duke University, Durham, North Carolina 27710

We have applied techniques of gene expression analysis to the analysis of human breast cancer by identifying metagene models with the capacity to discriminate breast tumors based on estrogen receptor (ER) status as well as the propensity for lymph node metastasis. We assess the utility and validity of these models in predicting status of tumors in cross-validation determinations. The practical value of such approaches relies on the ability not only to assess relative probabilities of clinical outcomes for future samples but also to provide an honest assessment of the uncertainties associated with such predictive classifications, based on the selection of gene subsets for each validation analysis. This latter point is of critical importance to the ability of applying these methodologies to clinical assessment of tumor phenotype. It is also clear from ER predictions that these analyses identify genes known to be involved in ER function but also identify new candidate genes involved in ER function. We believe these gene expression phenotypes have the potential to characterize the complex genetic alterations that typify the neoplastic state in a way that truly reflects the complexity of the regulatory pathways that are affected.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by the The Endocrine Society.